Reducing surgical site infections and mortality among obstetric surgical patients in Tanzania: a pre-evaluation and postevaluation of a multicomponent safe surgery intervention.
cross-sectional survey
hospital-based study
intervention study
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
02
09
2021
accepted:
01
11
2021
entrez:
8
12
2021
pubmed:
9
12
2021
medline:
19
3
2022
Statut:
ppublish
Résumé
Despite ongoing maternal health interventions, maternal deaths in Tanzania remain high. One of the main causes of maternal mortality includes postoperative infections. Surgical site infection (SSI) rates are higher in low/middle-income countries (LMICs), such as Tanzania, compared with high-income countries. We evaluated the impact of a multicomponent safe surgery intervention in Tanzania, hypothesising it would (1) increase adherence to safety practices, such as the WHO Surgical Safety Checklist (SSC), (2) reduce SSI rates following caesarean section (CS) and (3) reduce CS-related perioperative mortality rates (POMRs). We conducted a pre-cross-sectional/post-cross-sectional study design to evaluate WHO SSC utilisation, SSI rates and CS-related POMR before and 18 months after implementation. Our interventions included training of inter-professional surgical teams, promoting use of the WHO SSC and introducing an infection prevention (IP) bundle for all CS patients. We assessed use of WHO SSC and SSI rates through random sampling of 279 individual CS patient files. We reviewed registers and ward round reports to obtain the number of CS performed and CS-related deaths. We compared proportions of individuals with a characteristic of interest during pre-implementation and post implementation using the two-proportion z-test at p≤0.05 using STATA V.15. The SSC utilisation rate for CS increased from 3.7% (5 out of 136) to 95.1% (136 out of 143) with p<0.001. Likewise, the proportion of women with SSI after CS reduced from 14% during baseline to 1% (p=0.002). The change in SSI rate after the implementation of the safe surgery interventions is statistically significant (p<0.001). The CS-related POMR decreased by 38.5% (p=0.6) after the implementation of safe surgery interventions. Our findings show that our intervention led to improved utilisation of the WHO SSC, reduced SSIs and a drop in CS-related POMR. We recommend replication of the interventions in other LMICs.
Identifiants
pubmed: 34876458
pii: bmjgh-2021-006788
doi: 10.1136/bmjgh-2021-006788
pmc: PMC8655579
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : AHRQ HHS
ID : R18 HS024235
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: The authors declare no competing interests.
Références
BMC Pregnancy Childbirth. 2015 Apr 12;15:91
pubmed: 25884350
N Engl J Med. 2009 Jan 29;360(5):491-9
pubmed: 19144931
Qual Manag Health Care. 2011 Oct-Dec;20(4):293-7
pubmed: 21971026
Lancet Glob Health. 2019 Apr;7(4):e513-e522
pubmed: 30879511
PLoS One. 2019 Apr 9;14(4):e0214807
pubmed: 30964909
BMC Res Notes. 2014 Aug 07;7:500
pubmed: 25100042
Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8
pubmed: 1334988
Obstet Gynecol. 2017 Oct;130(4):735-746
pubmed: 28885421
BJOG. 2011 Jan;118(2):193-201
pubmed: 21159119
BMJ Open. 2019 Oct 7;9(10):e031800
pubmed: 31594896
Br J Anaesth. 2018 Jan;120(1):146-155
pubmed: 29397122
World J Surg. 2019 Jan;43(1):24-35
pubmed: 30128771
Am J Perinatol. 2021 Jun;38(7):690-697
pubmed: 31887748
BMJ Open Qual. 2020 Aug;9(3):
pubmed: 32788171
Trop Med Int Health. 2017 Apr;22(4):454-464
pubmed: 28072493
Am J Obstet Gynecol. 2010 Mar;202(3):310.e1-6
pubmed: 20207251
Arch Surg. 2010 Aug;145(8):721-5
pubmed: 20713922
Am Psychol. 2018 May-Jun;73(4):433-450
pubmed: 29792459
Antimicrob Resist Infect Control. 2014 Aug 11;3:25
pubmed: 25126415
Br J Surg. 2019 Jan;106(2):e44-e52
pubmed: 30620060
Lancet. 2018 Apr 21;391(10130):1589-1598
pubmed: 29306587
Antimicrob Resist Infect Control. 2020 May 19;9(1):69
pubmed: 32430026
Front Med (Lausanne). 2018 Apr 17;5:100
pubmed: 29719833
Lancet. 2015 Aug 8;386(9993):569-624
pubmed: 25924834
Surg Infect (Larchmt). 2020 Aug;21(6):478-494
pubmed: 31816263
BMC Res Notes. 2015 Aug 19;8:361
pubmed: 26285824
J Turk Ger Gynecol Assoc. 2013 Mar 01;14(1):28-34
pubmed: 24592067
World J Surg. 2020 Mar;44(3):689-695
pubmed: 31741072
Lancet. 2019 May 11;393(10184):1973-1982
pubmed: 30929893
Am J Obstet Gynecol. 2019 Aug;221(2):117.e1-117.e7
pubmed: 31055033
J Hosp Infect. 2016 Aug;93(4):355-9
pubmed: 27125664